Rapid identification of viridans streptococci by mass spectrometric discrimination.

PubWeight™: 2.49‹?› | Rank: Top 2%

🔗 View Article (PMC 1951256)

Published in J Clin Microbiol on June 06, 2007

Authors

C Friedrichs1, A C Rodloff, G S Chhatwal, W Schellenberger, K Eschrich

Author Affiliations

1: Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Liebigstr. 24, D-04105 Leipzig, Germany. claudia.friedrichs@medizin.uni-leipzig.de

Articles citing this

The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev (2015) 11.49

High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol (2010) 5.71

Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2009) 3.54

Comparison of direct colony method versus extraction method for identification of gram-positive cocci by use of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 2.67

Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev (2013) 2.34

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol (2010) 2.18

Rapid classification and identification of salmonellae at the species and subspecies levels by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry . Appl Environ Microbiol (2008) 1.86

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of clinically relevant bacteria. PLoS One (2011) 1.67

Optimizing identification of clinically relevant Gram-positive organisms by use of the Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system. J Clin Microbiol (2013) 1.40

Rapid Classification and Identification of Microcystis aeruginosa Strains Using MALDI-TOF MS and Polygenetic Analysis. PLoS One (2016) 1.37

Matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis of Gram-positive, catalase-negative cocci not belonging to the Streptococcus or Enterococcus genus and benefits of database extension. J Clin Microbiol (2012) 1.31

Evaluation of several biochemical and molecular techniques for identification of Streptococcus pneumoniae and Streptococcus pseudopneumoniae and their detection in respiratory samples. J Clin Microbiol (2012) 1.30

MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol (2015) 1.26

Differentiation of Streptococcus pneumoniae from nonpneumococcal streptococci of the Streptococcus mitis group by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 1.23

It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations. J Clin Microbiol (2010) 1.22

Differentiation of Streptococcus pneumoniae conjunctivitis outbreak isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol (2008) 1.16

Identification of clinical isolates of α-hemolytic streptococci by 16S rRNA gene sequencing, matrix-assisted laser desorption ionization-time of flight mass spectrometry using MALDI Biotyper, and conventional phenotypic methods: a comparison. J Clin Microbiol (2012) 1.05

Contribution of Streptococcus anginosus to infections caused by groups C and G streptococci, southern India. Emerg Infect Dis (2010) 1.03

Identification and typing of Lactococcus lactis by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol (2010) 1.01

Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of viridans group streptococci. Eur J Clin Microbiol Infect Dis (2013) 1.00

Streptococcus gordonii septic arthritis: two cases and review of literature. BMC Infect Dis (2012) 0.97

Leptospira spp. strain identification by MALDI TOF MS is an equivalent tool to 16S rRNA gene sequencing and multi locus sequence typing (MLST). BMC Microbiol (2012) 0.97

Evaluation of species-specific score cutoff values of routinely isolated clinically relevant bacteria using a direct smear preparation for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based bacterial identification. Eur J Clin Microbiol Infect Dis (2011) 0.96

Rapid MALDI-TOF mass spectrometry strain typing during a large outbreak of Shiga-Toxigenic Escherichia coli. PLoS One (2014) 0.94

Contribution of plasminogen activation towards the pathogenic potential of oral streptococci. PLoS One (2010) 0.92

A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med Sci Monit (2012) 0.91

Developments for improved diagnosis of bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis (2014) 0.90

Phenotypic and genotypic identification of streptococci and related bacteria isolated from bovine intramammary infections. Acta Vet Scand (2013) 0.90

Viridans Group Streptococci clinical isolates: MALDI-TOF mass spectrometry versus gene sequence-based identification. PLoS One (2015) 0.87

Improved Differentiation of Streptococcus pneumoniae and Other S. mitis group Streptococci by MALDI Biotyper Using an Improved MALDI Biotyper Database Content and a Novel Result Interpretation Algorithm. J Clin Microbiol (2017) 0.83

MALDI-TOF mass spectrometry proteomic based identification of clinical bacterial isolates. Indian J Med Res (2014) 0.83

Rapid discrimination of Bifidobacterium animalis subspecies by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Food Microbiol (2011) 0.81

Evaluation of a simple protein extraction method for species identification of clinically relevant staphylococci by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 0.81

Discrimination of Enterobacteriaceae and Non-fermenting Gram Negative Bacilli by MALDI-TOF Mass Spectrometry. Open Microbiol J (2013) 0.81

Comparing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Phenotypic and Molecular Methods for Identification of Species within the Streptococcus anginosus Group. J Clin Microbiol (2015) 0.78

Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry. PLoS One (2011) 0.78

Rapid identification of oral Actinomyces species cultivated from subgingival biofilm by MALDI-TOF-MS. J Oral Microbiol (2015) 0.77

Clinical presentation of infective endocarditis caused by different groups of non-beta haemolytic streptococci. Eur J Clin Microbiol Infect Dis (2015) 0.77

Performance of the matrix-assisted laser desorption ionization time-of-flight mass spectrometry system for rapid identification of streptococci: a review. Eur J Clin Microbiol Infect Dis (2017) 0.75

Identification of viridans streptococci With Matrix-Assisted Laser Desorption & Ionization Time-of-flight Mass Spectrometry by an In-house Method and a Commercially Available System. Ann Lab Med (2017) 0.75

Articles cited by this

Gene organization and primary structure of a ribosomal RNA operon from Escherichia coli. J Mol Biol (1981) 29.04

Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus. Int J Syst Bacteriol (1995) 5.91

Identification of streptococci to species level by sequencing the gene encoding the manganese-dependent superoxide dismutase. J Clin Microbiol (1998) 3.84

Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol (1993) 3.36

The rapid identification of intact microorganisms using mass spectrometry. Nat Biotechnol (1996) 3.06

MALDI-TOF mass spectrometry of bacteria. Mass Spectrom Rev (2002) 2.37

Identification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. J Clin Microbiol (2006) 2.34

An algorithm for automated bacterial identification using matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem (2000) 1.81

Identification of clinically relevant viridans group streptococci to the species level by PCR. J Clin Microbiol (1997) 1.77

Rapid characterization of spores of Bacillus cereus group bacteria by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry. Appl Environ Microbiol (2000) 1.55

Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region. J Clin Microbiol (2004) 1.52

Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases. J Clin Microbiol (2006) 1.48

Identification of "Streptococcus milleri" group isolates to the species level with a commercially available rapid test system. J Clin Microbiol (1995) 1.48

Thoracic empyema in patients with community-acquired pneumonia. Am J Med (2006) 1.47

groESL sequence determination, phylogenetic analysis, and species differentiation for viridans group streptococci. J Clin Microbiol (2002) 1.45

PCR detection and identification of oral streptococci in saliva samples using gtf genes. Diagn Microbiol Infect Dis (2004) 1.45

A novel method for protein secondary structure prediction using dual-layer SVM and profiles. Proteins (2004) 1.38

Characterisation of bacteria by matrix-assisted laser desorption/ionisation and electrospray mass spectrometry. FEMS Microbiol Rev (2000) 1.26

Testing the significance of microorganism identification by mass spectrometry and proteome database search. Anal Chem (2000) 1.22

Rapid typing of bacteria using matrix-assisted laser desorption ionisation time-of-flight mass spectrometry and pattern recognition software. J Microbiol Methods (2002) 1.21

Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis (2002) 1.20

Rapid discrimination between strains of beta haemolytic streptococci by intact cell mass spectrometry. Indian J Med Res (2004) 1.09

Differentiation of mutans streptococci by intact cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Oral Microbiol Immunol (2005) 1.09

Use of the Phoenix automated system for identification of Streptococcus and Enterococcus spp. J Clin Microbiol (2006) 1.02

Identification of the anginosus group within the genus Streptococcus using polymerase chain reaction. FEMS Microbiol Lett (2004) 1.02

Rapid microorganism identification with on-slide proteolytic digestion followed by matrix-assisted laser desorption/ionization tandem mass spectrometry and database searching. Rapid Commun Mass Spectrom (2002) 0.97

Spontaneous cervical paraspinal and epidural giant abscess in a child--case report--. Neurol Med Chir (Tokyo) (2005) 0.83

Pyrolysis mass spectrometry characterisation and numerical taxonomy of Aeromonas spp. Antonie Van Leeuwenhoek (1994) 0.83

Application of pyrolysis mass spectrometry to the classification and identification of mycobacteria. Rev Infect Dis (1982) 0.81

Articles by these authors

SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol (1997) 3.01

alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. Mol Microbiol (2001) 2.81

EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect (2011) 2.65

Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect Immun (1992) 2.48

The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect Immun (1997) 2.25

Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood (2000) 2.12

Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun (1999) 1.94

Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli. Infect Immun (1987) 1.90

Botulinum ADP-ribosyltransferase C3. Purification of the enzyme and characterization of the ADP-ribosylation reaction in platelet membranes. Eur J Biochem (1988) 1.90

The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. Mol Microbiol (1991) 1.86

Trigger for group A streptococcal M1T1 invasive disease. FASEB J (2006) 1.77

Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci (1997) 1.73

Entry and intracellular survival of group B streptococci in J774 macrophages. Infect Immun (1996) 1.71

Domain structure and conserved epitopes of Sfb protein, the fibronectin-binding adhesin of Streptococcus pyogenes. Mol Microbiol (1994) 1.66

Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol Microbiol (2000) 1.56

Identification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcus. J Bacteriol (2001) 1.48

Characterization of a novel fibronectin-binding surface protein in group A streptococci. Mol Microbiol (1995) 1.47

Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin. FEBS Lett (1987) 1.44

Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells. Cell Microbiol (2000) 1.36

Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI. J Infect Dis (1999) 1.32

Expression of the fibronectin-binding components of Streptococcus pyogenes in Escherichia coli demonstrates that they are proteins. Mol Microbiol (1991) 1.31

Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles. Clin Infect Dis (1996) 1.31

ADP-ribosylation of skeletal muscle and non-muscle actin by Clostridium perfringens iota toxin. Eur J Biochem (1988) 1.31

The role played by the group A streptococcal negative regulator Nra on bacterial interactions with epithelial cells. Mol Microbiol (2001) 1.31

Genetic control of susceptibility to group A streptococcal infection in mice. J Infect Dis (2001) 1.31

Mediation of adherence of streptococci to human endothelial cells by complement S protein (vitronectin). Infect Immun (1988) 1.27

M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate. FASEB J (2008) 1.25

Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother (1992) 1.24

Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates. J Infect Dis (1998) 1.23

Hydrogen peroxide-mediated killing of Caenorhabditis elegans by Streptococcus pyogenes. Infect Immun (2002) 1.18

Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection (2013) 1.17

Two distinct pathways for the invasion of Streptococcus pyogenes in non-phagocytic cells. Cell Microbiol (2000) 1.15

Quantification of bacteria in oral samples by competitive polymerase chain reaction. J Dent Res (1999) 1.15

Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob Agents Chemother (2001) 1.14

In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. Antimicrob Agents Chemother (2003) 1.14

Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur J Clin Microbiol Infect Dis (2000) 1.14

A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3. J Biol Chem (2000) 1.12

Identification and strain differentiation of 'Bacteroides fragilis group' species and Prevotella bivia by PCR fingerprinting. Anaerobe (1995) 1.12

First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis (2012) 1.11

Binding of vitronectin to opa-expressing Neisseria gonorrhoeae mediates invasion of HeLa cells. Infect Immun (1997) 1.11

A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence. Infect Immun (1998) 1.11

Differentiation of mutans streptococci by intact cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Oral Microbiol Immunol (2005) 1.09

Distribution and antigenicity of fibronectin binding proteins (SfbI and SfbII) of Streptococcus pyogenes clinical isolates from the northern territory, Australia. J Clin Microbiol (2000) 1.07

SfbII protein, a fibronectin binding surface protein of group A streptococci, is a serum opacity factor with high serotype-specific apolipoproteinase activity. FEMS Microbiol Lett (1999) 1.07

Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet (2000) 1.06

The fibronectin binding domain of the Sfb protein adhesin of Streptococcus pyogenes occurs in many group A streptococci and does not cross-react with heart myosin. Microb Pathog (1994) 1.05

Fibrinogen binding inhibits the fixation of the third component of human complement on surface of groups A, B, C, and G streptococci. Microbiol Immunol (1985) 1.05

A lithium chloride-extracted, broad-spectrum-adhesive 42-kilodalton protein of Staphylococcus epidermidis is ornithine carbamoyltransferase. Infect Immun (1999) 1.04

Molecular analysis of the bvg-repressed urease of Bordetella bronchiseptica. Microb Pathog (1996) 1.02

Substitution of Arg214 at the substrate-binding site of p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens. Eur J Biochem (1992) 1.01

Streptococcal invasion. Curr Opin Microbiol (1999) 1.01

Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect (2002) 1.00

Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis. Clin Microbiol Infect (2000) 1.00

Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route. Eur J Immunol (1998) 0.99

Correlation of epithelial cell invasiveness of group B streptococci with clinical source of isolation. Microb Pathog (1995) 0.99

Heterogeneity of fibronectin reactivity among streptococci as revealed by binding of fibronectin fragments. Comp Immunol Microbiol Infect Dis (1987) 0.98

Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J Neural Transm (Vienna) (1999) 0.98

Structure of a group C streptococcal protein that binds to fibrinogen, albumin and immunoglobulin G via overlapping modules. Biochem J (1996) 0.96

Fc-mediated nonspecific binding between fibronectin-binding protein I of Streptococcus pyogenes and human immunoglobulins. J Immunol (1999) 0.95

Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea. Diagn Microbiol Infect Dis (2001) 0.95

The prognosis of mild cognitive impairment in the elderly. J Neural Transm Suppl (1998) 0.95

Botulinum ADP-ribosyltransferase C3 but not botulinum neurotoxins C1 and D ADP-ribosylates low molecular mass GTP-binding proteins. FEBS Lett (1987) 0.95

Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Clin Microbiol Infect (2005) 0.94

Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease. Clin Infect Dis (2006) 0.93

Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete. J Biol Chem (2008) 0.92

Binding of human fibrinogen and its polypeptide chains to group B streptococci. Med Microbiol Immunol (1983) 0.92

Role played by the fibronectin-binding protein SfbI (Protein F1) of Streptococcus pyogenes in bacterial internalization by epithelial cells. J Infect Dis (1999) 0.92

Characterization of binding of human alpha 2-macroglobulin to group G streptococci. Infect Immun (1983) 0.92

Novel complex formed between a nonproteolytic cell wall protein of group A streptococci and alpha 2-macroglobulin. J Bacteriol (1987) 0.91

Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci. Infect Immun (1996) 0.91

Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile. Clin Microbiol Infect (2003) 0.90

A real-time PCR assay for the differentiation of Candida species. J Appl Microbiol (2010) 0.90

In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria. Antimicrob Agents Chemother (1999) 0.90

Release of Fc-receptors after streptococcal lysis induced by a lytic enzyme from Streptomyces globisporus. Med Microbiol Immunol (1986) 0.90

Comparison of profiles of key periodontal pathogens in periodontium and endodontium. Endod Dent Traumatol (2000) 0.89

Ouabain inhibits the increase due to palytoxin of cation permeability of erythrocytes. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.89

Palytoxin both induces and inhibits the release of histamine from rat mast cells. Int Arch Allergy Appl Immunol (1982) 0.89

Interactions of immunoglobulin G, fibrinogen and fibronectin with Staphylococcus hyicus and Staphylococcus intermedius. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.89

Rapid identification of oral anaerobic bacteria cultivated from subgingival biofilm by MALDI-TOF-MS. Oral Microbiol Immunol (2008) 0.88

Overexpression of catalytically active yeast (Saccharomyces cerevisiae) fructose-1,6-bisphosphatase in Escherichia coli. Biol Chem Hoppe Seyler (1994) 0.88

The hemopexin-type repeats of human vitronectin are recognized by Streptococcus pyogenes. Biochem Biophys Res Commun (1997) 0.87

Occurrence of Bacteroides fragilis enterotoxin gene-carrying strains in Germany and the United States. J Clin Microbiol (2000) 0.87

Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response. Infect Immun (2001) 0.87

Similarity of activation of yeast phosphofructokinase by AMP and fructose-2,6-bisphosphate. Biochem Biophys Res Commun (1983) 0.87

Meningitis due to Haemophilus influenzae type f in an 8-year-old girl with congenital humoral immunodeficiency. Infection (2004) 0.86

In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria. Int J Antimicrob Agents (2000) 0.86

Conserved anchorless surface proteins as group A streptococcal vaccine candidates. J Mol Med (Berl) (2012) 0.86

Isolation and characterization of an allelic cDNA for human muscle fructose-1,6-bisphosphatase. Gene (1998) 0.86

Quantification of Microthrix parvicella in activated sludge bacterial communities by real-time PCR. Lett Appl Microbiol (2005) 0.86

Biocompatibility of bacterial contaminated prosthetic meshes and porcine dermal collagen used to repair abdominal wall defects. Langenbecks Arch Surg (2006) 0.85

Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain. Brain Res Mol Brain Res (2001) 0.85

Human leptin forms complexes with alpha 2-macroglobulin which are recognized by the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Eur J Endocrinol (1998) 0.85

Interactions of plasma proteins with group A, B, C and G streptococci. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.85

Identification and characterization of a novel secreted immunoglobulin binding protein from group A streptococcus. Infect Immun (2001) 0.85

[Bacteriologic findings before and in transcervical chorionic villi biopsy and their clinical relevance]. Geburtshilfe Frauenheilkd (1991) 0.85

Kinetic modelling of yeast phosphofructokinase. Acta Biol Med Ger (1979) 0.85

Infections caused by Stenotrophomonas maltophilia--a prospective study. Infection (2001) 0.85

Pericarditis after allogeneic peripheral blood stem cell transplantation caused by Legionella pneumophila (non-serogroup 1). Infection (2001) 0.85